{"@id":"https://bioecon.ru/technology/in-vitro-manufactured-platelets/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://en.bioecon.ru/technology/in-vitro-manufactured-platelets/","json":"https://en.bioecon.ru/api/v1/technology/in-vitro-manufactured-platelets/index.json"},"id":"in-vitro-manufactured-platelets","industries":["pharma","biomanufacturing"],"lang":"en","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/pbs-biotech/","https://bioecon.ru/companies/roche-holding/","https://bioecon.ru/companies/impextraco/","https://bioecon.ru/companies/becton-dickinson/","https://bioecon.ru/companies/impacfat/","https://bioecon.ru/companies/orf-genetics/","https://bioecon.ru/companies/bionet/"]},"maturity":7,"name":"In-Vitro Manufactured Platelets","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"iPSC differentiation to megakaryocytes"},{"n":2,"title":"Biomimetic shear-stress bioreactors"},{"n":3,"title":"Platelet purification and isolation"},{"n":4,"title":"Functional aggregation and clotting"}],"summary":"Scalable ex-vivo directed differentiation of human induced pluripotent stem cell (iPSC) master banks into CD41+/CD42b+ mature megakaryocytes, followed by microfluidic shear-flow bioreactor stimulation to produce donor-independent, sterile, HLA-universal platelets for clinical transfusion.","url":"/technology/in-vitro-manufactured-platelets/","verified":"2026-11-22"}